Clinical efficacy of PARP inhibitors in breast cancer.
Pandya K, Scher A, Omene C, Ganesan S, Kumar S, Ohri N, Potdevin L, Haffty B, Toppmeyer DL, George MA.
Pandya K, et al. Among authors: potdevin l.
Breast Cancer Res Treat. 2023 Jul;200(1):15-22. doi: 10.1007/s10549-023-06940-0. Epub 2023 May 2.
Breast Cancer Res Treat. 2023.
PMID: 37129747
Review.